AAAAAA
Results:
1-7
|
Results: 7
Authors:
Delaloge, S
Yovine, A
Taamma, A
Riofrio, M
Brain, E
Raymond, E
Cottu, P
Goldwasser, F
Jimeno, J
Misset, JL
Marty, M
Cvitkovic, E
Citation: S. Delaloge et al., Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity, J CL ONCOL, 19(5), 2001, pp. 1248-1255
Authors:
Taamma, A
Misset, JL
Riofrio, M
Guzman, C
Brain, E
Lazaro, LL
Rosing, H
Jimeno, JM
Cvitkovic, E
Citation: A. Taamma et al., Phase I and pharmacokinetic study of ecteinaseidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors, J CL ONCOL, 19(5), 2001, pp. 1256-1265
Authors:
van Kesteren, C
Cvitkovic, E
Taamma, A
Lopez-Lazaro, L
Jimeno, JM
Guzman, C
Mathot, RAA
Schellens, JHM
Misset, JL
Brain, E
Hillebrand, MJX
Rosing, H
Beijnen, JH
Citation: C. Van Kesteren et al., Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study, CLIN CANC R, 6(12), 2000, pp. 4725-4732
Authors:
Fandi, A
Bachouchi, M
Azli, N
Taamma, A
Boussen, H
Wibault, P
Eschwege, F
Armand, JP
Simon, J
Cvitkovic, E
Citation: A. Fandi et al., Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type, J CL ONCOL, 18(6), 2000, pp. 1324-1330
Authors:
Delaloge, S
Laadem, A
Taamma, A
Chouaki, N
Cvitkovic, E
Pautier, P
Misset, JL
Lhomme, C
Citation: S. Delaloge et al., Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer, AM J CL ONC, 23(6), 2000, pp. 569-574
Authors:
Hasbini, A
Mahjoubi, R
Fandi, A
Chouaki, N
Taamma, A
Lianes, P
Cortes-Funes, H
Alonso, S
Armand, JP
Cvitkovic, E
Raymond, E
Citation: A. Hasbini et al., Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type, ANN ONCOL, 10(4), 1999, pp. 421-425
Authors:
Taamma, A
Fandi, A
Azli, N
Wibault, P
Chouaki, N
Hasbini, A
Couteau, C
Armand, JP
Cvitkovic, E
Citation: A. Taamma et al., Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin,and cisplatin for patients with locally advanced, metastatic, or recurrentundifferentiated carcinoma of the nasopharyngeal type, CANCER, 86(7), 1999, pp. 1101-1108
Risultati:
1-7
|